Skip to main content
Clinical Trials/CTRI/2024/05/067666
CTRI/2024/05/067666Not yet recruitingUnknown

Prospective observational study on the efficacy and safety of Hydra transcatheter aortic valve - AIIMS Hydra Registry - NI

Sahajanand Medical Technologies Limited (SMT)0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • 1. Patients affected by symptomatic severe aortic stenosis (NYHA class = II) eligible for TAVI procedure as per local Heart Team evaluation
  • 2. Full understanding and willing to provide informed consent to study enrolment

Exclusion Criteria

  • 1. Contraindications to TAVI (e.g., anatomically phenotypes, intracardiac mass, thrombus, vegetation, endocarditis)
  • 2. Refusal to provide informed consent to study enrolment

Investigators

Sponsor
Sahajanand Medical Technologies Limited (SMT)

Similar Trials